Johnson & Johnson price target raised to $166 from $162 at Guggenheim
Guggenheim analyst Vamil Divan raised the firm’s price target on Johnson & Johnson to $166 from $162 and keeps a Neutral rating on the ...
Why Johnson & Johnson (JNJ) Is One of the Best Cancer Stock to Buy According to Hedge Funds
We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to ...
Is Johnson & Johnson (JNJ) the Most Promising Dividend Stock According to Hedge Funds?
We recently compiled a list of the 10 Most Promising Dividend Stocks According to Hedge Funds. In this article, we are going ...
On3 on MSN1d
Jimmie Johnson, Shaq face off in free throw competition to determine Daytona 500 paint scheme
Jimmie Johnson wanted it, and he got it. Last Sunday, the seven-time NASCAR Cup Series champion challenged NBA legend Shaquille O’Neal to a free throw competition. O’Neal agreed, and the two recently ...
Why Johnson & Johnson’s CEO Welcomes Scrutiny
Duato discusses the split of the business, dealing with the scrutiny brought about by lawsuits, and 2025 priorities.